Literature DB >> 3556167

Control of replication of plasmid R1: translation of the 7k reading frame in the RepA mRNA leader region counteracts the interaction between CopA RNA and CopT RNA.

E G Wagner, J von Heijne, K Nordström.   

Abstract

Replication of IncFII plasmids is regulated through the expression of a gene, repA. The RepA protein is rate-limiting for initiation of replication. The main negative control is exerted by a countertranscript, CopA RNA, that binds to the complementary region of the RepA mRNA, thereby inhibiting the formation of the RepA protein. The target region for CopA RNA, CopT, is located upstream of the RepA coding region. An open reading frame for a putative 7k protein overlaps the CopT sequence. Here we show by using lacZ fusions that the 7k gene is expressed. We constructed a translation start mutation in order to abolish formation of the 7k protein. This resulted in a 10-fold decrease in repA expression. The 7k protein produced in trans did not reverse this effect, so the 7k protein per se does not control expression of repA. However, translation of the 7k coding sequence must influence CopA/CopT RNA recognition, since ribosomes will transiently disrupt the target hairpin. We propose here a novel mechanism that affects the level of gene expression: the 7k region of the RepA mRNA is a leader sequence that is involved in expression of the downstream gene; translation of the 7k region competes with a negative control system involving RNA-RNA interaction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556167      PMCID: PMC553424          DOI: 10.1002/j.1460-2075.1987.tb04783.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

1.  Isolation and characterization of the minimal fragment required for autonomous replication ("basic replicon") of a copy mutant (pKN102) of the antibiotic resistance factor R1.

Authors:  R Kollek; W Oertel; W Goebel
Journal:  Mol Gen Genet       Date:  1978-06-01

Review 2.  In vitro synthesis of protein in microbial systems.

Authors:  G Zubay
Journal:  Annu Rev Genet       Date:  1973       Impact factor: 16.830

3.  Purification and properties of an aminopeptidase from Escherichia coli.

Authors:  V M Vogt
Journal:  J Biol Chem       Date:  1970-09-25       Impact factor: 5.157

4.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

5.  Clustering of genes involved in replication, copy number control, incompatibility, and stable maintenance of the resistance plasmid R1drd-19.

Authors:  S Molin; P Stougaard; B E Uhlin; P Gustafsson; K Nordström
Journal:  J Bacteriol       Date:  1979-04       Impact factor: 3.490

6.  A general method for maximizing the expression of a cloned gene.

Authors:  T M Roberts; R Kacich; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA.

Authors:  S N Cohen; A C Chang; L Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

8.  Construction and characterization of new cloning vehicles. II. A multipurpose cloning system.

Authors:  F Bolivar; R L Rodriguez; P J Greene; M C Betlach; H L Heyneker; H W Boyer; J H Crosa; S Falkow
Journal:  Gene       Date:  1977       Impact factor: 3.688

9.  The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.

Authors:  J Shine; L Dalgarno
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Post-transcriptional control of expression of the repA gene of plasmid R1 mediated by a small RNA molecule.

Authors:  J Light; S Molin
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  12 in total

1.  Novel alleles of the Escherichia coli dnaA gene are defective in replication of pSC101 but not of oriC.

Authors:  M D Sutton; J M Kaguni
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

2.  Secondary structure analysis of the RepA mRNA leader transcript involved in control of replication of plasmid R1.

Authors:  M Ohman; E G Wagner
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

3.  Role of countertranscript RNA in the copy number control system of an IncB miniplasmid.

Authors:  J Praszkier; P Bird; S Nikoletti; J Pittard
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

4.  Organization of the replication control region of plasmid ColIb-P9.

Authors:  C Hama; T Takizawa; H Moriwaki; Y Urasaki; K Mizobuchi
Journal:  J Bacteriol       Date:  1990-04       Impact factor: 3.490

5.  DNA sequencing and analysis of the low-Ca2+-response plasmid pCD1 of Yersinia pestis KIM5.

Authors:  R D Perry; S C Straley; J D Fetherston; D J Rose; J Gregor; F R Blattner
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 6.  Replication of plasmids in gram-negative bacteria.

Authors:  U Kües; U Stahl
Journal:  Microbiol Rev       Date:  1989-12

7.  Replication control in plasmid R1: duplex formation between the antisense RNA, CopA, and its target, CopT, is not required for inhibition of RepA synthesis.

Authors:  E G Wagner; P Blomberg; K Nordström
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

8.  Replication control of plasmid R1: RepA synthesis is regulated by CopA RNA through inhibition of leader peptide translation.

Authors:  P Blomberg; K Nordström; E G Wagner
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

9.  Control of replication of plasmid R1: structures and sequences of the antisense RNA, CopA, required for its binding to the target RNA, CopT.

Authors:  C Persson; E G Wagner; K Nordström
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

10.  Control of replication of plasmid R1: the duplex between the antisense RNA, CopA, and its target, CopT, is processed specifically in vivo and in vitro by RNase III.

Authors:  P Blomberg; E G Wagner; K Nordström
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.